Back to XTX Topco Ltd XTX Topco Ltd

VRAXVRAX
4 quarters

Position history for XTX Topco LtdXTX Topco Ltd's holdings in VIRAX BIOLABS GROUP LTD

No. XTX Topco exited its VRAX (Virax Biolabs Group) position in Q1 2026. Its Q4 2025 13F listed 21,437 shares worth $7,413. XTX Topco first reported VRAX in Q4 2024 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$26,692

Total Shares Change

-11,863

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$0.20
0
2025-Q4
New
21,437
-
$7,4130.0%$0.35
22
2025-Q1
Exited
0
-100.0%
$00.0%$1.16
0
2024-Q4
New
11,863
-
$26,6920.0%$2.06
27

Other major holders of VRAX: RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, Squarepoint Ops LLC, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used